ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1066

Temporal Trends and Outcomes of Acute Myocardial Infarction in Systemic Lupus Erythematosus Hospitalizations

Narender Annapureddy1, Achint Patel2, Rabi Yacoub3, Krishna Pakanati4, Shiv Agarwal5, Priya Simoes6, Sunil Kamat7, Alexandre Benjo8 and Girish Nadkarni9, 1Rheumatology and Immunology, Vanderbilt University, Nashville, TN, 2Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, 3Icahn School of Medicine at Mount Sinai, New York, NY, 4Gateway Medical Center, Clarksville, TN, 5Cardiology, University of Arkansas Medical Sciences, Little Rock, AR, 6Internal Medicine, St.Lukes Roosevelt Hospital Center at Mount Sinai, New York, NY, 7Critical Care, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India, 8Ochsner Clinic Foundation, New Orleans, NY, 9Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cardiovascular disease and morbidity and mortality, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment II: Patient-Reported Measures, Outcomes and Reporting

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Cardiovascular disease remains the
most common cause of mortality in Systemic lupus erythematosus (SLE). Some
studies suggest that mortality due to acute myocardial infarction (AMI) in SLE
has decreased. We aimed to evaluate temporal trends of incidence and mortality
of SLE in AMI hospitalizations in a nationally representative sample.

Methods: We reviewed Nationwide Inpatient
Sample (NIS) data over 10 year period from 2002-2011 for adult AMI
hospitalizations as a primary diagnosis with SLE as secondary diagnosis using
validated ICD9-CM codes. We calculated unadjusted proportions of mortality
yearly and used survey logistic regression to calculate adjusted odds ratios (aOR) for hospital mortality overall and after stratifying
for age (≤50 vs. >50).

Results: We identified a total of 6588743 AMI hospitalizations from 2002-2011 of which 20508 (0.31%) had a
diagnosis for SLE. The proportion of patients with SLE in AMI hospitalizations
increased from 0.27% in 2002 to 0.39% in 2011.  SLE hospitalizations were
younger (60.5 vs. 67.8 years<0.01); more female (80.4% vs. 40.1%;
p<0.01); with a higher proportion of African-Americans (21.4% vs. 9.2%;
p<0.01) and a higher Charlson comorbidity index
(Mean 2 vs. 1.5; p<0.01).
The
unadjusted mortality rates in SLE hospitalizations yearly were similar to
hospitalizations without SLE (Figure 1).
After adjusting for age, gender, race, Charlson comorbidity index, hospital level characteristics,
cardiac procedures, SLE hospitalizations had similar odds-ratio for hospital
mortality (aOR=0.98; 95% CI= 0.83-1.16; p=0.54)
compared to non-SLE hospitalizations. In hospitalizations ≤50 years,
there was no significant difference in the adjusted odds of hospital mortality
(aOR=0.88; 95% C 0.56-1.37; p=0.57)

Conclusion:  In hospital mortality in SLE
hospitalizations with AMI was similar to non-SLE hospitalizations. This could
be related to better disease recognition, newer modalities, risk modification
and increased life expectancy in SLE patients.

Figure 1
Proportion of Mortality in AMI Hospitalizations Stratified by Systemic Lupus
Erythematosus Status


Disclosure: N. Annapureddy, None; A. Patel, None; R. Yacoub, None; K. Pakanati, None; S. Agarwal, None; P. Simoes, None; S. Kamat, None; A. Benjo, None; G. Nadkarni, None.

To cite this abstract in AMA style:

Annapureddy N, Patel A, Yacoub R, Pakanati K, Agarwal S, Simoes P, Kamat S, Benjo A, Nadkarni G. Temporal Trends and Outcomes of Acute Myocardial Infarction in Systemic Lupus Erythematosus Hospitalizations [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/temporal-trends-and-outcomes-of-acute-myocardial-infarction-in-systemic-lupus-erythematosus-hospitalizations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/temporal-trends-and-outcomes-of-acute-myocardial-infarction-in-systemic-lupus-erythematosus-hospitalizations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology